Cancer

Titlesort descending Average Rating
Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial 70.00%
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study. 90.00%
Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. 50.00%
Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins 80.00%
Sanguinarine suppresses prostate tumor growth and inhibits survivin expression. 80.00%
Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. 90.00%
Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain 70.00%
Sen. Ron Johnson Sends Letter to Sec. of Defense Demanding Information on Shockingly High COVID-19 Vaccine Injury Among Military Personnel 100.00%
Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial. 80.00%
Serum calcium and the risk of prostate cancer. 60.00%
Serum cytokines in pancreatic cancer: Correlation with outcome 40.00%
Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones
Some pharmacological properties of prolonged administration of Ukrain in rodents 50.00%
SONIA POULTON INTERVIEWS DR. MIKAEL NORDFORS CORRUPTED MEDICINE AND ALTERNATIVE TREATMENTS. 70.00%
Stoppa Massmordet! 100.00%
Strong synergy of heat and modulated electromagnetic field in tumor cell killing. 60.00%
Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes 70.00%
Survivin and pancreatic cancer. 60.00%
Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and 60.00%
Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer. 60.00%
Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. 70.00%
Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growt 80.00%
Systematic review of the treatment of cancer-associated anorexia and weight loss. 60.00%
Systematic review: Cyclo-oxygenase-2 in human oesophageal adenocarcinogenesis. 50.00%
Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for NSCLC. 70.00%
Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. 90.00%
Systems biology: a therapeutic target for tumor therapy. 86.67%
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer 70.00%
Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. 30.00%
Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines 70.00%
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Onco 40.00%
Teratological evaluation of Ukrain in hamsters and rats
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse 80.00%
The anti-angiogenic basis of metronomic chemotherapy. 85.00%
The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking and 80.00%
The antimitotic effects of Ukrain, a Chelidonium majus alkaloid derivative, are reversible in vitro. 80.00%
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline 70.00%
The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 ... 80.00%
The effect of whole-body hyperthermia combined with 'metronomic' chemotherapy on rat mammary adenocarcinoma metastases. 80.00%
The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways 70.00%
The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky 60.00%
The efficacy of corticosteroids in restoring hearing in patients undergoing conservative management of acoustic neuromas.' 70.00%
The emerging low-dose therapy for advanced cancers. 80.00%
The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary stu 60.00%
The immunomodulating preparation Ukrain does not induce anaphylactic sensitization in mice and guinea pigs 20.00%
The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. 80.00%
The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing
The influence of glucose, succinate, pH of the medium and higher temperature on the cytotoxic activity of the preparation Ukrain 80.00%
The influence of the novel drug Ukrain on hemo- and immunopoiesis at the time of its maximum radioprotective effect 60.00%
The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy 30.00%
The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. 70.00%
The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alp 90.00%
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. 80.00%
The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications 90.00%
The PEP-C regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy. 90.00%
The present state of antineoplaston research (1) 90.00%
The Result of Vitamin C Treatment of Patients with Cancer: Conditions Influencing the Effectiveness 60.00%
The story of the cancer medicine Ukrain and Wassil Nowicky 55.00%
The use of mushroom glucans and proteoglycans in cancer treatment. 90.00%
The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhib
The way ‘Covid deaths’ are being counted is a national scandal 80.00%
Theoretical grounds and experimental confirmation of the antiviral effect of the 60.00%
Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carci
Therapeutic vaccination against advanced pancreatic cancer by autologous dendritic cells pulsed with a MUC1 peptide: Preclinic.. 60.00%
Therapeutic vaccination with an autologous TriMix-Dendritic cell vaccine combined with sequential interferon alfa-2b in ........ 90.00%
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors. 50.00%
Todoxin, the immune stimulant from Serbia 86.36%
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expressio 80.00%
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. 80.00%
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer. 50.00%
Trans Arterial Chemo Embolization(TACE) 40.00%
Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecula 80.00%
Treatment of advanced pancreatic cancer with opioid growth factor: phase I. 90.00%
Treatment of locally advanced pancreatic cancer with concurrent uftoral and radiotherapy. Results from 64 patients treated from 80.00%
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. 80.00%
Tumor pO(2) as a Surrogate Marker to Identify Therapeutic Window during Metronomic Chemotherapy of 9L Gliomas. 60.00%
Tumor therapy with Amanita phalloides (death cap): stabilization of B-cell chronic lymphatic leukemia. 90.00%
Tumoral angiogenesis: review of the literature. 50.00%
Ukrain 62.22%
Ukrain - a new cancer cure? A systematic review of randomised clinical trials. 90.00%
Ukrain acts by inhibition of tubulin polymerization in normal and malignant cell lines. 80.00%
Ukrain both as an anti cancer and immunoregulatory agent 60.00%
Ukrain Debate 1: What is the active Substance of Ukrain? 80.00%
Ukrain in the treatment of urethral recurrent carcinoma (case report) 50.00%
Ukrain monotherapy in malignant melanoma (case report) 80.00%
Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report) 40.00%
Ukrain therapy of a recurrent astrocytoma of the optic nerve (case report) 20.00%
Ukrain therapy of recurrent breast cancer with lung metastases (case report) 80.00%
Ukrain therapy of stage T1N0M0 bladder cancer patients 60.00%
Ukrain treatment in a patient with breast carcinoma 70.00%
Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. 50.00%
Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report) 50.00%
Ukrain treatment in carcinoma of the cervix (case report) 60.00%
Ukrain treatment in carcinoma of the oesophagus (case report) 70.00%
Ukrain with chemotherapy in malignant melanoma (case report) 50.00%
Ukrain: acute toxicity after intravenous, intramuscular and oral administration in rats 40.00%
Ukrain: Debated Subjects 80.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 60.00%
Update on pilot study on antitumor efficacy of intravenously applied synergistic combinations of diflunisal, PAS, and aspirin in patients with advanced solid tumors. 90.00%
Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. 90.00%

Pages